Поражение органа зрения при COVID-19. Часть 1: участие глаза в передаче вируса SARS-CoV-2 и осложнения со стороны переднего отрезка

Поражение глаза при COVID-19 может развиться на любой стадии заболевания. Вирусная рибонуклеиновая кислота обнаружена в глазных тканях, но роль глаза как пути заражения еще предстоит обосновать. Офтальмологические проявления могут быть характерным признаком COVID-19 или развиться через несколько недель после выздоровления. Офтальмологи должны быть осведомлены о возможных связях офтальмопатологии с SARS-CoV-2 для целенаправленного сбора анамнеза, обнаружения специфических признаков, назначения необходимых анализов и тем самым для снижения уровня распространения инфекции, а также для ранней диагностики и лечения осложнений, угрожающих жизни и зрению. В первой части обзора приводятся сведения о возможном участии глаза в заражении SARS-CoV-2 и распространении инфекции. Рассмотрены клинические проявления поражения переднего отрезка глаза.

1. Нероев В.В., Кричевская Г.И., Балацкая Н.В. COVID-19 и проблемы офтальмологии. Российский офтальмологический журнал. 2020; 13 (4): 99–104. https://doi.org/10.21516/2072-0076-2020-13-4-99-104

2. Нероев В.В., Киселева Т.Н., Елисеева Е.К. Офтальмологические аспекты коронавирусной инфекции. Российский офтальмологический журнал. 2021; 14 (1): 7–14. https://doi.org/10.21516/2072-0076-2021-14-1-7-14

3. Тахчиди Х.П., Тахчиди Н.Х., Мовсесян М.Х. COVID-19 в офтальмологической практике. Медицина экстремальных ситуаций. 2020; (4): 53–8. https://doi.org/10.47183/mes.2020.017

4. Курышева Н.И. Организация офтальмологической помощи в условиях пандемии COVID-19. Москва: ГНЦ ФМБЦ; 2021.

5. Курышева Н.И., Печенкина А.А., Гончарова А.С. Методы обследования больных глаукомой в период пандемии COVID-19. Вестник офтальмологии. 2021; 137 (2): 75–83. https://doi.org/10.17116/oftalma202113702175

6. Cheema M., Aghazadeh H., Nazarali S., et al. Keratoconjunctivitis as the initial medical presentation of the novel coronavirus disease 2019 (COVID-19). Can. J. Ophthalmol. 2020; 55 (4): e 125-9. https://doi.org/10.1016/j.jcjo.2020.03.003

7. Zhang X., Chen X., Chen L., et al. The evidence of SARS-CoV-2 infection on ocular surface. Ocul. Surf. 2020; 18 (3): 360–2. https://doi.org/10.1016/j.jtos.2020.03.010

8. Lu C.W., Liu X.F., Jia Z.F. 2019-nCoV transmission through the ocular surface must not be ignored. Lancet. 2020; 395 (10224): e39. https://doi.org/10.1016/S0140-6736(20)30313-5

9. Seah I., Agrawal R. Can the Coronavirus Disease 2019 (COVID-19) affect the eyes? A review of coronaviruses and ocular implications in humans and animals. Ocul. Immunol. Inflamm. 2020; 28 (3): 391–5. https://doi.org/10.1080/09273948.2020.1738501

10. World Health Organization. (2020). Origin of SARS-CoV-2, 26 March 2020. World Health Organization. Available at: https://apps.who.int/iris/handle/10665/332197

11. Chan J.F., Kok K.H., Zhu Z., et al. Genomic characterization of the 2019 novel human-pathogenic coronavirus isolated from a patient with atypical pneumonia after visiting Wuhan. Emerg. Microbes Infect. 2020; 9 (1): 221–36. https://doi.org/10.1080/22221751.2020.1719902

12. Jiang R.D., Liu M.Q., Chen Y., et al. Pathogenesis of SARS-CoV-2 in transgenic mice expressing human angiotensin-converting enzyme 2. Cell. 2020; 182: 50–8. https://doi.org/10.1016/j.cell.2020.05.027

13. Report of the WHO-China Joint Mission on Coronavirus Disease 2019 (COVID-19). February 2020. World Health Organization; 2020: 16–24.

14. World Health Organization. (2020). Laboratory testing of 2019 novel coronavirus (2019-nCoV) in suspected human cases: interim guidance, 17 January 2020. World Health Organization. Available at: https://apps.who.int/iris/handle/10665/330676

15. Loon S.-C., Teoh S.C.B., Oon L.L.E. et al. The severe acute respiratory syndrome coronavirus in tears. Br. J. Ophthalmol. 2004; 88 (7): 861–3. https://doi.org/10.1136/bjo.2003.035931

16. Chan W.M., Yuen K.S., Fan D.S., et al. Tears and conjunctival scrapings for coronavirus in patients with SARS. Br. J. Ophthalmol. 2004; 88 (7): 968–9. https://doi.org/10.1136/bjo.2003.039461

17. Yan A. Chinese expert who came down with Wuhan coronavirus after saying it was controllable thinks he was infected through his eyes. China: South China Morning Post. 2020. Available at: https://www.scmp.com/news/china/article/3047394/chinese-expert-who-came-down-wuhan-coronavirus-aftersayingit-was [Accessed 26 June 2020].

18. Lawrenson J.G., Buckley R.J. COVID-19 and the eye. Ophthalmic Physiol. Opt. 2020; 40 (4): 383–8. https://doi.org/10.1111/opo.12708

19. Ulhaq Z.S., Soraya G.V. The prevalence of ophthalmic manifestations in COVID-19 and the diagnostic value of ocular tissue/fluid. Graefes Arch. Clin. Exp. Ophthalmol. 2020; 258 (6): 1351–2. https://doi.org/10.1007/s00417-02004695-8

20. Xia J., Tong J., Liu M., Shen Y., Guo D. Evaluation of coronavirus in tears and conjunctival secretions of patients with SARS-CoV-2 infection. J. Med. Virol. 2020; 92 (6): 589–94. doi:10.1002/jmv.25725

21. Wu P., Duan F., Luo C., et al. Characteristics of ocular findings of patients with Coronavirus Disease 2019 (COVID-19) in Hubei Province, China. JAMA Ophthalmol. 2020; 138 (5): 575. doi:10.1001/jamaophthalmol.2020.1291

22. Zhou Y., Duan C., Zeng Y., et al. Ocular findings and proportion with conjunctival SARS-COV-2 in COVID-19 patients. Ophthalmology. 2020; 127 (7): 982–3. doi:10.1016/j.ophtha.2020.04.028

23. Zhou Y., Zeng Y., Tong Y., Chen C. Ophthalmologic evidence against the interpersonal transmission of 2019 novel coronavirus through conjunctiva. MedRxiv.; 2020. doi:10.1101/2020.02.11.20021956

24. Zou L., Ruan F., Huang M., et al. SARS-CoV-2 viral load in upper respiratory specimens of infected patients. N. Engl. J. Med. 2020; 382 (12): 1177–9. doi:10.1056/NEJMc2001737

25. Hong N., Yu W., Xia J., et al. Evaluation of ocular symptoms and tropism of SARS-CoV-2 in patients confirmed with COVID-19. Acta Ophthalmol. 2020; 98 (5): e 649–55. doi:10.1111/aos.14445

26. Hu Y., Chen T., Liu M., et al. Positive detection of SARS-CoV-2 combined HSV1 and HHV6B virus nucleic acid in tear and conjunctival secretions of a non-conjunctivitis COVID-19 patient with obstruction of common lacrimal duct. Acta Ophthalmol. 2020; 98 (8): 859–63. doi:10.1111/aos.14456

27. Hui K.P.Y., Cheung M.C., Perera R., et al. Tropism, replication competence, and innate immune responses of the coronavirus SARS-CoV-2 in human respiratory tract and conjunctiva: an analysis in ex-vivo and in-vitro cultures. Lancet Respir. Med. 2020; 8 (7): 687–95. doi:10.1016/S2213-2600(20)30193-4

28. White A.J., Cheruvu S.C., Sarris M., et al. Expression of classical components of the renin-angiotensin system in the human eye. J. Renin Angiotensin Aldosterone Syst. 2015; 16 (1): 59–66. doi:10.1177/1470320314549791

29. Sungnak W., Huang N., Becavin C., et al. SARS-CoV-2 entry factors are highly expressed in nasal epithelial cells together with innate immune genes. Nat. Med. 2020; 26 (5): 681–7. doi:10.1038/s41591-020-0868-6

30. Lange C., Wolf J., Auw-Haedrich C., et al. Expression of the COVID-19 receptor ACE2 in the human conjunctiva. J. Med. Virol. 2020; 92 (10): 2081–6. doi:10.1002/jmv.25981

31. Ma D., Chen C.B., Jhanji V., et al. Expression of SARS-CoV-2 receptor ACE2 and TMPRSS2 in human primary conjunctival and pterygium cell lines and in mouse cornea. Eye (Lond). 2020; 34 (7): 1212-9. doi:10.1038/s41433-020-0939-4

32. Leonardi A., Rosani U., Brun P. Ocular surface expression of SARS-CoV-2 receptors. Ocul. Immunol. Inflamm. 2020; 28 (5): 735–8. doi:10.1080/09273948.2020.1772314

33. Lang J., Yang N., Deng J., et al. Inhibition of SARS pseudovirus cell entry by lactoferrin binding to heparan sulfate proteoglycans. PLoS One. 2011; 6 (8): e23710. doi:10.1371/journal.pone.0023710

34. Seah I.Y.J., Anderson D.E., Kang A.E.Z., et al. Assessing viral shedding and infectivity of tears in Coronavirus Disease 2019 (COVID-19) patients. Ophthalmology. 2020; 127 (7): 977–9. doi:10.1016/j.ophtha.2020.03.026

35. Xie H.-T., Jiang S.-Y., Xu -K.-K., et al. SARS-CoV-2 in the ocular surface of COVID-19 patients. Eye Vis (Lond). 2020; 92 (1): 23. doi:10.1186/s40662020-00189-0

36. Interim Guidelines for Collecting and Handling of Clinical Specimens for COVID-19. National Center for Immunization and Respiratory Diseases (NCIRD). Division of Viral Diseases. Available at: https://stacks.cdc.gov/view/cdc/86167

37. He X., Lau E.H.Y., Wu P., et al. Temporal dynamics in viral shedding and transmissibility of COVID-19. Nat Med. 2020; 26 (5): 672–5. doi:10.1038/s41591-020-0869-5

38. Chen L., Deng C., Chen X., et al. Ocular manifestations and clinical characteristics of 535 cases of COVID-19 in Wuhan, China: a cross-sectional study. Acta Ophthalmol. 2020; 98 (8): e 951–9. doi:10.1111/aos.14472

39. Chen L., Liu M., Zhang Z., et al. Ocular manifestations of a hospitalised patient with confirmed 2019 novel coronavirus disease. Br. J. Ophthalmol. 2020; 104 (6): 748–51. doi:10.1136/bjophthalmol-2020-316304

40. Nayak B., Poddar C., Panigrahi M.K., Tripathy S., Mishra B. Late manifestation of follicular conjunctivitis in ventilated patient following COVID-19 positive severe pneumonia. Indian J. Ophthalmol. 2020; 68 (8): 1675–7. doi:10.4103/ijo.IJO_1682_20.

41. Belser J.A., Rota P.A., Tumpey T.M. Ocular tropism of respiratory viruses. Microbiol. Mol. Biol. Rev. 2013; 77 (1): 144–56. doi:10.1128/MMBR.00058-12

42. Baughman B.D., Hansemann B.K., Shah M.M., Weizer J.S. Drive-through intraocular pressure checks during the COVID-19 pandemic. J Glaucoma. 2021; 30 (3): 223–6. doi:10.1097/IJG.0000000000001748

43. Jain N., Kaur S., Kopsachilis N., Zia R. Risk of airborne COVID-19 transmission while performing Humphrey visual field testing. J. Glaucoma. 2021; 30 (3): 219–22. doi:10.1097/IJG.0000000000001771

44. Napoli P.E., Nioi M., d’Aloja E., Fossarello M. Safety recommendations and medical liability in ocular surgery during the COVID-19 pandemic: an unsolved dilemma. J. Clin. Med. 2020; 9 (5): 1403. doi:10.3390/jcm9051403

45. Casagrande M., Fitzek A., Spitzer M.S., et al. Presence of SARSCoV-2 RNA in the cornea of viremic patients with COVID-19. JAMA Ophthalmol. 2021; 139 (4): 383–8. doi:10.1001/jamaophthalmol.2020.6339

46. Aggarwal K., Agarwal A., Jaiswal N., et al. Ocular surface manifestations of coronavirus disease 2019 (COVID-19): A systematic review and meta-analysis. PLoS One. 2020; 15 (11): e0241661. doi:10.1371/journal.pone.0241661

47. Sindhuja K., Lomi N., Asif M.I., Tandon R. Clinical profile and prevalence of conjunctivitis in mild COVID-19 patients in a tertiary care COVID-19 hospital: A retrospective cross-sectional study. Indian J. Ophthalmol. 2020; 68 (8): 1546–50. doi:10.4103/ijo.IJO_1319_20

48. Guo D., Xia J., Wang Y., et al. Relapsing viral keratoconjunctivitis in COVID-19: a case report. Virol. J. 2020; 17 (1): 97. doi:10.1186/s12985-020-01370-6

49. Navel V., Chiambaretta F., Dutheil F. Haemorrhagic conjunctivitis with pseudomembranous related to SARS-CoV-2. Am. J. Ophthalmol Case Rep. 2020; 19: 100735. doi:10.1016/j.ajoc.2020.100735

50. Otaif W., Al Somali A.I., Al Habash A. Episcleritis as a possible presenting sign of the novel coronavirus disease: A case report. Am. J. Ophthalmol. Case Rep. 2020; 20: 100917. doi:10.1016/j.ajoc.2020.100917

51. Mangana C.M., Kargacin A.B., Barraquer R.I. Episcleritis as an ocular manifestation in a patient with COVID-19. Acta Ophthalmol. 2020; 98 (8): e1056–7. doi:10.1111/aos.14484

52. Meduri A., Oliverio G.W., Mancuso G., et al. Ocular surface manifestation of COVID-19 and tear film analysis. Sci Rep. 2020; 10 (1): 20178. doi:10.1038/s41598-020-77194-9

53. Sen M., Honavar S.G., Sharma N., Sachdev M.S. COVID-19 and Eye: A Review of Ophthalmic Manifestations of COVID-19. Indian J. Ophthalmol. 2021; 69 (3): 488–509. doi:10.4103/ijo.IJO_297_21

54. Scalinci S.Z., Trovato Battagliola E. Conjunctivitis can be the only presenting sign and symptom of COVID-19. IDCases. 2020; 20: e00774. doi:10.1016/j.idcr.2020.e00774

55. Guan W.J., Ni Z.Y., Hu Y., et al. China Medical Treatment Expert Group for Covid-19. Clinical Characteristics of Coronavirus Disease 2019 in China. N. Engl. J Med. 2020; 382 (18): 1708–20. doi:10.1056/NEJMoa2002032

56. Colavita F., Lapa D., Carletti F., et al. SARS-CoV-2 Isolation from ocular secretions of a patient with COVID-19 in Italy with prolonged viral RNA detection. Ann. Intern. Med. 2020; 173 (3): 242–3. doi:10.7326/M20-1176

57. Daruich A., Martin D., Bremond-Gignac D. Unilateral conjunctivitis as first presentation of Coronavirus Disease 2019 (COVID-19): A telemedicine diagnosis. J. Fr. Ophtalmol. 2020; 43 (5): e167–8. doi:10.1016/j.jfo.2020.04.001

58. Khavandi S., Tabibzadeh E., Naderan M., Shoar S. Corona virus disease-19 (COVID-19) presenting as conjunctivitis: atypically high-risk during a pandemic. Cont. Lens Anterior Eye. 2020; 43 (3): 211–2. doi:10.1016/j.clae.2020.04.010

59. Salducci M., La Torre G. COVID-19 emergency in the cruise's ship: a case report of conjunctivitis. Clin. Ter. 2020; 171 (3): e189–91. doi:10.7417/CT.2020.2212

60. Atum M., Boz A.A.E., ak r B., et al. Evaluation of conjunctival swab PCR results in patients with SARS-CoV-2 infection. Ocul. Immunol. Inflam. 2020; 28 (5): 745–8. doi:10.1080/09273948.2020.1775261

61. Lan Q.Q., Zeng S.M., Liao X., et al. A special on epidemic prevention and control: screening for novel coronavirus related conjunctivitis among the patients with coronavirus disease 2019. Zhonghua Yan Ke Za Zhi. 2020; 56 (6): 433–7. doi:10.3760/cma.j.cn112142-20200322-00213

62. Karimi S., Arabi A., Shahraki T., Safi S. Detection of severe acute respiratory syndrome Coronavirus-2 in the tears of patients with Coronavirus disease 2019. Eye (Lond). 2020; 34 (7): 1220–3. doi:10.1038/s41433-020-0965-2

63. Goel R., Arora R., Chhabra M., Kumar S. Viral shedding in tears of COVID-19 cases presenting as conjunctivitis. Indian J. Ophthalmol. 2020; 68 (10): 2308. doi:10.4103/ijo.IJO_2567_20

64. Tyagi R., Dadia S., Sharma S., et al. Ocular manifestations in Covid-19 positive patients admitted to a Tertiary care centre in Uttarakhand, India: A prospective study. International J. Health and Clinical Research. 2021; 4 (6): 225–8.

65. Bostanci Ceran B., Ozates S. Ocular manifestations of coronavirus disease 2019. Graefes Arch. Clin. Exp. Ophthalmol. 2020; 258 (9): 1959–63. doi:10.1007/s00417-020-04777-7